is tirzepatide fda approved for obesity F.D.A. Approves New Drug That Will Compete With Wegovy TrimRX | Semaglutide vs Tirzepatide:

The STEP (Semaglutide Treatment Effect in People with obesity) trial program showed average weight reductions of approximately 15% of initial body weight over 68 weeks in individuals without diabetes, with somewhat lower reductions (about 9-10%) in those with type 2 diabetes

She thought it might be due to stress

Weve established that while many medications can influence plasma donation eligibilityranging from antiplatelets and anticoagulants to drugs harmful to unborn babiesSemaglutide itself is generally not listed as a direct deferral by major donation organizations

If you're seeing multiple healthcare professionals (GP, specialist weight management service, sports medicine practitioner), ensure they are all aware of both your Wegovy prescription and creatine supplementation to facilitate coordinated care

Is health insurance accepted